| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Aclysiran, an RNAi therapeutic agent targeting ACLY, treats hypercholesterolemia and atherosclerosis in ApoE –/– mice
|
Chen, Meijie
|
|
|
14 |
12 |
p. 5505-5508
|
artikel
|
| 2 |
AKR1C1 interacts with STAT3 to increase intracellular glutathione and confers resistance to oxaliplatin in colorectal cancer
|
Fu, Zhiwen
|
|
|
14 |
12 |
p. 5305-5320
|
artikel
|
| 3 |
A microfluidic coculture model for mapping signaling perturbations and precise drug screening against macrophage-mediated dynamic myocardial injury
|
Gao, Zhao
|
|
|
14 |
12 |
p. 5393-5406
|
artikel
|
| 4 |
A morphologically transformable hypoxia-induced radical anion for tumor-specific photothermal therapy
|
Wang, Hongyu
|
|
|
14 |
12 |
p. 5407-5417
|
artikel
|
| 5 |
Avenanthramide A potentiates Bim-mediated antineoplastic properties of 5-fluorouracil via targeting KDM4C/MIR17HG/GSK-3β negative feedback loop in colorectal cancer
|
Fu, Rong
|
|
|
14 |
12 |
p. 5321-5340
|
artikel
|
| 6 |
Cell carriers change the in vivo fate of nanoparticles
|
Li, Xiaotong
|
|
|
14 |
12 |
p. 5515-5517
|
artikel
|
| 7 |
Comparison of Jinzhen oral liquid and ambroxol hydrochloride and clenbuterol hydrochloride oral solution in the treatment of acute bronchitis in children: A multicenter, non-inferiority, prospective, randomized controlled trial
|
Fan, Qinhua
|
|
|
14 |
12 |
p. 5186-5200
|
artikel
|
| 8 |
Controlling tumor progression and recurrence in mice through combined treatment with a PD-L1 inhibitor and a designer Salmonella strain that delivers GM-CSF
|
Jeon, Heung Jin
|
|
|
14 |
12 |
p. 5479-5492
|
artikel
|
| 9 |
Counteracting Alzheimer's disease via normalizing neurovascular unit with a self-regulated multi-functional nano-modulator
|
Xia, Xue
|
|
|
14 |
12 |
p. 5464-5478
|
artikel
|
| 10 |
Cover Story
|
|
|
|
14 |
12 |
p. xiii
|
artikel
|
| 11 |
Development of a bacteria-nanosapper for the active delivery of ZIF-8 particles containing therapeutic genes for cancer immune therapy
|
Qiao, Yiting
|
|
|
14 |
12 |
p. 5418-5434
|
artikel
|
| 12 |
Discovery of a novel exceptionally potent and orally active Nur77 ligand NB1 with a distinct binding mode for cancer therapy
|
Chen, Jun
|
|
|
14 |
12 |
p. 5493-5504
|
artikel
|
| 13 |
Discovery of a potent PROTAC degrader for RNA demethylase FTO as antileukemic therapy
|
Liu, Lu
|
|
|
14 |
12 |
p. 5382-5392
|
artikel
|
| 14 |
Discovery of highly potent phosphodiesterase-1 inhibitors by a combined-structure free energy perturbation approach
|
Li, Zhe
|
|
|
14 |
12 |
p. 5357-5369
|
artikel
|
| 15 |
DNMT3A loss drives a HIF-1-dependent synthetic lethality to HDAC6 inhibition in non-small cell lung cancer
|
Zhang, Jiayu
|
|
|
14 |
12 |
p. 5219-5234
|
artikel
|
| 16 |
Dual alarmin-receptor-specific targeting peptide systems for treatment of sepsis
|
Mun, Seok-Jun
|
|
|
14 |
12 |
p. 5451-5463
|
artikel
|
| 17 |
Emerging interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitors or degraders as therapeutic agents for autoimmune diseases and cancer
|
Feng, Yifan
|
|
|
14 |
12 |
p. 5091-5105
|
artikel
|
| 18 |
Heterologous biosynthesis of saponin adjuvants from Quillaja saponaria: A symbolic achievement in metabolic engineering
|
Chen, Weiqiang
|
|
|
14 |
12 |
p. 5518-5520
|
artikel
|
| 19 |
Identification of USP2 as a novel target to induce degradation of KRAS in myeloma cells
|
Wang, Yingying
|
|
|
14 |
12 |
p. 5235-5248
|
artikel
|
| 20 |
Intestinal epithelial cell NCoR deficiency ameliorates obesity and metabolic syndrome
|
Hou, Shaocong
|
|
|
14 |
12 |
p. 5267-5285
|
artikel
|
| 21 |
Microneedles as transdermal drug delivery system for enhancing skin disease treatment
|
Wu, Chaoxiong
|
|
|
14 |
12 |
p. 5161-5180
|
artikel
|
| 22 |
Nanoengineered mitochondria enable ocular mitochondrial disease therapy via the replacement of dysfunctional mitochondria
|
Wang, Yi
|
|
|
14 |
12 |
p. 5435-5450
|
artikel
|
| 23 |
New functions of oxylipins released by pyroptotic cells
|
Xu, Hui
|
|
|
14 |
12 |
p. 5509-5511
|
artikel
|
| 24 |
Pretheranostic agents with extraordinaryNIRF/photoacoustic imaging performanceand photothermal oncotherapy efficacy
|
Shi, Liu
|
|
|
14 |
12 |
p. 5370-5381
|
artikel
|
| 25 |
Recent advances in reactive oxygen species (ROS)-responsive drug delivery systems for photodynamic therapy of cancer
|
Hu, Danrong
|
|
|
14 |
12 |
p. 5106-5131
|
artikel
|
| 26 |
Reductive stress—a common metabolic feature of obesity and cancer
|
Luo, Man
|
|
|
14 |
12 |
p. 5181-5185
|
artikel
|
| 27 |
Respiratory delivered vaccines: Current status and perspectives in rational formulation design
|
Wu, Lan
|
|
|
14 |
12 |
p. 5132-5160
|
artikel
|
| 28 |
Spinal astrocyte-derived interleukin-17A promotes pain hypersensitivity in bone cancer mice
|
Liu, Huizhu
|
|
|
14 |
12 |
p. 5249-5266
|
artikel
|
| 29 |
Sunlenca® (Lenacapavir): A first-in-class, long-acting HIV-1 capsid inhibitor for treating highly multidrug-resistant HIV-1 infection
|
Ma, Chunhua
|
|
|
14 |
12 |
p. 5512-5514
|
artikel
|
| 30 |
Table of Contents
|
|
|
|
14 |
12 |
p. iii-xii
|
artikel
|
| 31 |
Targeted inhibition of Gus-expressing Enterococcus faecalis to promote intestinal stem cell and epithelial renovation contributes to the relief of irinotecan chemotoxicity by dehydrodiisoeugenol
|
Gao, Ruiyang
|
|
|
14 |
12 |
p. 5286-5304
|
artikel
|
| 32 |
Thio-ProTide strategy: A novel H2S donor–drug conjugate (DDC) alleviates hepatic injury via innate lysosomal targeting
|
Jin, Haowen
|
|
|
14 |
12 |
p. 5341-5356
|
artikel
|
| 33 |
UBE2G2 inhibits vasculogenic mimicry and metastasis of uveal melanoma by promoting ubiquitination of LGALS3BP
|
Zhao, Andi
|
|
|
14 |
12 |
p. 5201-5218
|
artikel
|
Tijdschrift beschrijving